Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of Emerging Strategies.

IF 3.7 2区医学 Q2 INFECTIOUS DISEASES

Current HIV/AIDS Reports Pub Date : 2025-02-21 DOI:10.1007/s11904-025-00727-2

Kalpana Gopalkrishnan, Roksana Karim

{"title":"Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of Emerging Strategies.","authors":"Kalpana Gopalkrishnan, Roksana Karim","doi":"10.1007/s11904-025-00727-2","DOIUrl":null,"url":null,"abstract":"Purpose of review: Cervical cancer burden is disproportionately higher in low to middle income countries, especially in countries with a high human immunodeficiency virus (HIV) burden. This review investigates barriers to implementation and assesses current progress in cervical cancer screening in lower resource settings by reviewing technologies and strategies that have already been implemented in low to middle income countries.Recent findings: Several novel innovations embrace the recent World Health Organization (WHO) update to screening guidelines that recommends a \"screen and treat\" approach rather than a \"screen, triage and treat\" approach. Innovations include human papillomavirus (HPV) self-sampling, portable cervical visualization devices, and creative large-scale approaches to increase screening accessibility. Overall, a low-cost, accurate, point-of-care screening test could alleviate most of the barriers associated with cervical cancer screening in lower resource settings. Further research into the development of a low-cost HPV test in conjunction with the HPV vaccine and other screening tools could expedite progress.","PeriodicalId":10930,"journal":{"name":"Current HIV/AIDS Reports","volume":"22 1","pages":"18"},"PeriodicalIF":3.7000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842523/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current HIV/AIDS Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11904-025-00727-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Cervical cancer burden is disproportionately higher in low to middle income countries, especially in countries with a high human immunodeficiency virus (HIV) burden. This review investigates barriers to implementation and assesses current progress in cervical cancer screening in lower resource settings by reviewing technologies and strategies that have already been implemented in low to middle income countries.

Recent findings: Several novel innovations embrace the recent World Health Organization (WHO) update to screening guidelines that recommends a "screen and treat" approach rather than a "screen, triage and treat" approach. Innovations include human papillomavirus (HPV) self-sampling, portable cervical visualization devices, and creative large-scale approaches to increase screening accessibility. Overall, a low-cost, accurate, point-of-care screening test could alleviate most of the barriers associated with cervical cancer screening in lower resource settings. Further research into the development of a low-cost HPV test in conjunction with the HPV vaccine and other screening tools could expedite progress.

查看原文本刊更多论文

解决宫颈癌负担的全球差异：新兴战略的叙述审查。

审查目的：在低收入和中等收入国家，特别是在人类免疫缺陷病毒（艾滋病毒）负担高的国家，宫颈癌负担不成比例地高。本综述通过回顾中低收入国家已经实施的技术和战略，调查了在低资源环境中实施宫颈癌筛查的障碍，并评估了目前在宫颈癌筛查方面取得的进展。最近的发现：一些新颖的创新采用了世界卫生组织（世卫组织）最近更新的筛查指南，该指南建议采用“筛查和治疗”方法，而不是“筛查、分类和治疗”方法。创新包括人乳头瘤病毒（HPV）自采样，便携式宫颈可视化设备，以及创造性的大规模方法，以增加筛查的可及性。总之，低成本、准确、即时的筛查试验可以减轻资源匮乏地区宫颈癌筛查的大部分障碍。进一步研究开发一种低成本的HPV检测方法，并结合HPV疫苗和其他筛查工具，可能会加快进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current HIV/AIDS Reports INFECTIOUS DISEASES-

CiteScore

8.10

自引率

2.20%

发文量

期刊介绍： This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of HIV/AIDS. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antiretroviral therapies, behavioral aspects of management, and metabolic complications and comorbidity. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.